This goes in line with previous in-silico findings by Wiley et al. where the most prominent increased GPR68 expression was in pancreatic ductal adenocarcinoma, cervical squamous cell carcinoma, certain subtypes of breast adenocarcinoma and ovarian cancer (29). Here, GPR68 is linked to breast adenocarcinoma.